{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:56:38Z","timestamp":1781646998818,"version":"3.54.5"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic juvenile idiopathic arthritis (sJIA), a severe autoinflammatory subtype of JIA, presents diagnostic challenges due to non-specific clinical features and the absence of definitive biomarkers. Current ILAR classification criteria emphasize exclusion of mimicking conditions, yet misdiagnosis rates persist (20%-35%), particularly in early disease stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 15-year-old female presented with persistent high-grade fever, anemia (Hb: 84\u219264\u219273\u219291\u00a0g\/L), thrombocytosis (PLT 592\u21921,044\u2009\u00d7\u200910\u2079\/L), and iron overload. Initial evaluations excluded infections (CMV-positive, treated) but revealed hypocellular marrow (30%) and a polyclonal hypergammaglobulinemia. Naproxen-responsive fever, generalized lymphadenopathy (PET\/CT) and evanescent rash suggested autoinflammatory etiology. Hyperinflammation (CRP 265\u2192311\u00a0mg\/L, ferritin 1,083\u21921,271\u00a0\u00b5g\/L) and elevated IL-6 (272 ng\/L) emerged, with bone marrow ruling out malignancy (initially suspected MGUS based on the presence of M protein bands in serum protein electrophoresis and immunofixation electrophoresis). Final diagnosis aligned with systemic juvenile idiopathic arthritis (sJIA) per ILAR criteria, supported by rash, arthralgia, and IL-6 elevation. Tocilizumab rapidly resolved fever and inflammation. Ongoing multidisciplinary monitoring continues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case report highlights a pediatric sJIA patient exhibiting atypical monoclonal (M) protein expression\u2014a finding not typically associated with sJIA\u2014that complicated diagnostic evaluation. It illustrates how hematological abnormalities may complicate immunophenotypic interpretation in JIA, potentially contributing to diagnostic delays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06828-0","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:06:50Z","timestamp":1775117210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic challenges of systemic juvenile idiopathic arthritis with aberrant M-protein expression: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Shanshan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanmin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"2","key":"6828_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rhuematol. 2004;31(2):390\u20132.","journal-title":"J Rhuematol"},{"issue":"1","key":"6828_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2015.04.018","volume":"159","author":"N Bruck","year":"2015","unstructured":"Bruck N, Schnabel A, Hedrich CM. Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Clin Immunol (Orlando Fla). 2015;159(1):72\u201383.","journal-title":"Clin Immunol (Orlando Fla)"},{"issue":"11","key":"6828_CR3","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1093\/rheumatology\/keaa394","volume":"59","author":"GM Murray","year":"2020","unstructured":"Murray GM, Vastert SJ, Ramanan AV. Aiming high: quantifying inflammation in systemic onset juvenile idiopathic arthritis (sJIA), a multi-faceted and complex inflammatory disease. Rheumatology (Oxford). 2020;59(11):3124\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"6828_CR4","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1136\/annrheumdis-2015-207818","volume":"75","author":"S Yokota","year":"2016","unstructured":"Yokota S, Itoh Y, Morio T, Origasa H, Sumitomo N, Tomobe M, Tanaka K, Minota S. Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan. Ann Rheum Dis. 2016;75(9):1654\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6828_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","volume":"65","author":"JJY Lee","year":"2018","unstructured":"Lee JJY, Schneider R. Systemic Juvenile Idiopathic Arthritis. Pediatr Clin North Am. 2018;65(4):691\u2013709.","journal-title":"Pediatr Clin North Am"},{"key":"6828_CR6","doi-asserted-by":"crossref","unstructured":"Gurion R, Lehman TJ, Moorthy LN. Systemic arthritis in children: a review of clinical presentation and treatment. Int J Inflamm. 2012;2012:271569.","DOI":"10.1155\/2012\/271569"},{"issue":"12","key":"6828_CR7","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u2013548.","journal-title":"Lancet Oncol"},{"issue":"4","key":"6828_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamainternmed.2024.8124","volume":"185","author":"Y Liu","year":"2025","unstructured":"Liu Y, Parks AL. Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review. JAMA Intern Med. 2025;185(4):450\u20136.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"6828_CR9","first-page":"332","volume":"27","author":"S Liang","year":"2022","unstructured":"Liang S, Feng W, Ma H, Zhang L, Jia C. False positive results: a challenge for laboratory physicians and hematologists in treating multiple myeloma with daratumumab. Hematol (Amsterdam Netherlands). 2022;27(1):332\u20136.","journal-title":"Hematol (Amsterdam Netherlands)"},{"issue":"16","key":"6828_CR10","doi-asserted-by":"publisher","first-page":"e70128","DOI":"10.1002\/cam4.70128","volume":"13","author":"Y Shirouchi","year":"2024","unstructured":"Shirouchi Y, Kaihara K, Sekita T, Amano N, Nakayama K, Miyake K, Abe H, Oinuma H, Maruyama D. Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-\u03ba monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents. Cancer Med. 2024;13(16):e70128.","journal-title":"Cancer Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06828-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06828-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06828-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:23:27Z","timestamp":1781645007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06828-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6828"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06828-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of West China Hospital of Sichuan University (Approval No. 2024\u2009\u2212\u20091889) and complied with Declaration of Helsinki. Written informed consent was obtained from the subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parents for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}